234 related articles for article (PubMed ID: 20561186)
1. Evaluation of serum ferritin as a tumor marker for canine histiocytic sarcoma.
Friedrichs KR; Thomas C; Plier M; Andrews GA; Chavey PS; Young KM
J Vet Intern Med; 2010; 24(4):904-11. PubMed ID: 20561186
[TBL] [Abstract][Full Text] [Related]
2. Hyperferritinemia associated with malignant histiocytosis in a dog.
Newlands CE; Houston DM; Vasconcelos DY
J Am Vet Med Assoc; 1994 Sep; 205(6):849-51. PubMed ID: 7829379
[TBL] [Abstract][Full Text] [Related]
3. Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy.
Grobman M; Outi H; Rindt H; Reinero C
J Vet Intern Med; 2017 Sep; 31(5):1430-1440. PubMed ID: 28804921
[TBL] [Abstract][Full Text] [Related]
4. Hyperferritinemia is associated with short survival time in dogs with multicentric lymphoma.
Chikazawa S; Hori Y; Hoshi F; Kanai K; Ito N
J Vet Med Sci; 2015 Jul; 77(7):843-6. PubMed ID: 25715650
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein concentration in dogs with primary immune-mediated hemolytic anemia.
Griebsch C; Arndt G; Raila J; Schweigert FJ; Kohn B
Vet Clin Pathol; 2009 Dec; 38(4):421-5. PubMed ID: 19392754
[TBL] [Abstract][Full Text] [Related]
6. Change in serum ferritin concentration in experimentally induced anemia of chronic inflammation in dogs.
Chikazawa S; Nakazawa T; Hori Y; Hoshi F; Kanai K; Ito N; Orino K; Watanabe K; Higuchi S
J Vet Med Sci; 2013 Nov; 75(11):1419-26. PubMed ID: 23803460
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma.
Prouteau A; Denis JA; De Fornel P; Cadieu E; Derrien T; Kergal C; Botherel N; Ulvé R; Rault M; Bouzidi A; François R; Dorso L; Lespagnol A; Devauchelle P; Abadie J; André C; Hédan B
Sci Rep; 2021 Jan; 11(1):877. PubMed ID: 33441840
[TBL] [Abstract][Full Text] [Related]
8. Case-control study of plasma mean platelet component concentration and survival analysis for dogs with immune-mediated hemolytic anemia.
Zoia A; Gerou-Ferriani M; Drigo M; Caldin M
J Am Vet Med Assoc; 2018 Jun; 252(11):1384-1392. PubMed ID: 29772969
[TBL] [Abstract][Full Text] [Related]
9. Clinical prognostic factors in canine histiocytic sarcoma.
Dervisis NG; Kiupel M; Qin Q; Cesario L
Vet Comp Oncol; 2017 Dec; 15(4):1171-1180. PubMed ID: 27334037
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
Asada H; Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2015 Jun; 77(6):677-84. PubMed ID: 25715778
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors Associated with Development of Histiocytic Sarcoma in Bernese Mountain Dogs.
Ruple A; Morley PS
J Vet Intern Med; 2016 Jul; 30(4):1197-203. PubMed ID: 27160025
[TBL] [Abstract][Full Text] [Related]
12. Investigation of a screening programme and the possible identification of biomarkers for early disseminated histiocytic sarcoma in Bernese Mountain dogs.
Nielsen LN; McEvoy F; Jessen LR; Kristensen AT
Vet Comp Oncol; 2012 Jun; 10(2):124-34. PubMed ID: 22235831
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil Extracellular Traps in Plasma from Dogs with Immune-mediated Hemolytic Anemia.
Lawson C; Smith SA; O'Brien M; McMichael M
J Vet Intern Med; 2018 Jan; 32(1):128-134. PubMed ID: 29214674
[TBL] [Abstract][Full Text] [Related]
14. The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia.
Paes G; Paepe D; Meyer E; Kristensen AT; Duchateau L; Campos M; Daminet S
Acta Vet Scand; 2013 Oct; 55(1):74. PubMed ID: 24160183
[TBL] [Abstract][Full Text] [Related]
15. Use of serum concentrations of interleukin-18 and monocyte chemoattractant protein-1 as prognostic indicators in primary immune-mediated hemolytic anemia in dogs.
Kjelgaard-Hansen M; Goggs R; Wiinberg B; Chan DL
J Vet Intern Med; 2011; 25(1):76-82. PubMed ID: 21092010
[TBL] [Abstract][Full Text] [Related]
16. Hyperferritinemia in dogs with splenic hemangiosarcoma.
Chikazawa S; Hori Y; Hoshi F; Kanai K; Ito N; Higuchi S
J Vet Med Sci; 2013 Nov; 75(11):1515-8. PubMed ID: 23803459
[TBL] [Abstract][Full Text] [Related]
17. Anti-endothelial cell antibodies in dogs with immune-mediated hemolytic anemia and other diseases associated with high risk of thromboembolism.
Wells R; Guth A; Lappin M; Dow S
J Vet Intern Med; 2009; 23(2):295-300. PubMed ID: 19192144
[TBL] [Abstract][Full Text] [Related]
18. Perinuclear antineutrophil cytoplasmic autoantibodies in dogs infected with various vector-borne pathogens and in dogs with immune-mediated hemolytic anemia.
Karagianni AE; Solano-Gallego L; Breitschwerdt EB; Gaschen FP; Day MJ; Trotta M; Wieland B; Allenspach K
Am J Vet Res; 2012 Sep; 73(9):1403-9. PubMed ID: 22924722
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid A is not a marker for relapse of multicentric lymphoma in dogs.
Merlo A; Rezende BC; Franchini ML; Monteiro PR; Lucas SR
Vet Clin Pathol; 2008 Mar; 37(1):79-85. PubMed ID: 18366549
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases expression in spontaneous canine histiocytic sarcomas and its xenograft model.
Fayyad A; Lapp S; Risha E; Pfankuche VM; Rohn K; Barthel Y; Schaudien D; Baumgärtner W; Puff C
Vet Immunol Immunopathol; 2018 Apr; 198():54-64. PubMed ID: 29571518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
